Craneware (LON:CRW) Share Price Crosses Above 200-Day Moving Average of $1,876.65

Craneware plc (LON:CRW)’s share price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,876.65 ($23.36) and traded as high as GBX 2,240 ($27.88). Craneware shares last traded at GBX 2,240 ($27.88), with a volume of 33,066 shares trading hands.

Wall Street Analyst Weigh In

Separately, Berenberg Bank lifted their target price on Craneware from GBX 2,300 ($28.63) to GBX 2,600 ($32.37) and gave the stock a “buy” rating in a report on Monday, March 4th.

Craneware Trading Down 0.9 %

The firm has a market capitalization of £784.77 million, a price-to-earnings ratio of 10,571.43 and a beta of 0.14. The company has a quick ratio of 1.00, a current ratio of 0.78 and a debt-to-equity ratio of 19.15. The firm’s 50 day moving average is GBX 2,168 and its 200 day moving average is GBX 1,881.62.

Craneware Cuts Dividend

The business also recently announced a dividend, which was paid on Monday, April 15th. Investors of record on Thursday, March 21st were issued a GBX 13 ($0.16) dividend. This represents a dividend yield of 0.62%. The ex-dividend date was Thursday, March 21st. Craneware’s payout ratio is 13,809.52%.

Craneware Company Profile

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors.